Purchase Order 75D30120P08115
- Not listed
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a Firm Fixed Price Purchase Order to Integrated DNA Technologies, Inc. (IDT), a manufacturer of nucleic acid products, on June 2, 2020. The $154,671.98 contract supports COVID-19 response efforts and has a completion date of August 31, 2020. IDT, a for-profit organization, has an active Federal Supply Schedule contract with the Department of Veterans Affairs to provide oligonucleotides, probes, and...
- The Centers for Disease Control and Prevention (CDC) awarded a $249,445 firm-fixed-price purchase order to Integrated DNA Technologies, Inc. (IDT) to provide oligonucleotides and gene production in support of the development of COVID-19 vaccine candidates. The award does not have a set-aside designation. IDT is a major provider of specialized nucleic acid products and services to federal agencies, including the NIH, CDC, DoD, and USDA, through prime contracts and subcontracts. The company...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Integrated DNA Technologies, Inc. (IDT) for the delivery of primer kits and probe kits. The $154,671.98 contract has a completion date of October 2, 2020 and is associated with the Coronavirus COVID-19 national interest action. IDT, a manufacturer of nucleic acid products, has previously supplied the federal government with a range of goods and services including...
- Integrated DNA Technologies, Inc. (IDT) has been awarded a firm fixed price purchase order totaling $670,359.20 by the Centers for Disease Control and Prevention (CDC) to provide custom reagents for SARS-CoV-2 genomic sequencing through September 30, 2022. The products will support the CDC's detection and monitoring of COVID-19 variants. No set-aside designation was applied to this procurement. IDT will deliver the reagents from its location in Atlanta, Georgia under the base indefinite...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Integrated DNA Technologies, Inc. (IDT) for $16,438.00 in lab supplies. IDT is a manufacturer of nucleic acid products, including custom DNA and RNA oligonucleotides, gene fragments, next generation sequencing products, primers, probes, reagents, and research materials. IDT has held a Federal Supply Schedule contract with the Department of Veterans Affairs valued at...
- This is a $16,438.00 firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT) for the delivery of custom laboratory oligonucleotides. The contract has no set-aside designation. IDT is a leading manufacturer and supplier of specialized nucleic acid products and services to federal agencies, supporting initiatives such as biomedical research, pandemic response, and public health programs. This award is part of...
- This is a firm-fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. federal government. The $5,040 contract does not have a set-aside designation. Under this contract, IDT is supplying custom DNA and RNA oligonucleotides, gene fragments, next-generation sequencing products, primers, probes, and other reagents to support a...
- This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. government. The $214,978.20 firm-fixed-price purchase order is for "RAPID OLIGO AND DNA" products and services, which likely includes custom DNA and RNA oligonucleotides, gene fragments, primers, probes, and other reagents to support the CDC's biomedical research,...
- This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT) for the delivery of primers and probes. The contract, valued at $90,225.60, has a period of performance ending on March 13, 2020. IDT is a leading provider of specialized nucleic acid products and services to various federal agencies, including the CDC, supporting biomedical research, pandemic response, and public health initiatives. This award is...
- This contract was awarded to Integrated DNA Technologies, Inc. (IDT), a leading manufacturer and supplier of specialized nucleic acid products and services to the U.S. federal government. The contract is a Blanket Purchase Agreement (BPA) call with a ceiling value of $14,853.75 and a completion date of September 8, 2014. The funding agency is the Office of the Chief Operating Officer, a civilian agency. IDT has provided custom oligonucleotides, antisense oligonucleotides, DNA library kits, exome...
This is a $115,346.90 firm fixed-price purchase order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT), a manufacturer of nucleic acid products for the life sciences industry. The contract supports COVID-19 response efforts and is not set aside. IDT has a Federal Supply Schedule contract with the Department of Veterans Affairs to provide oligonucleotides, probes, and custom DNA/RNA synthesized products to support patient care and research. This $2.5 million, 5-year indefinite delivery/indefinite quantity vehicle allows the VA to procure specialized supplies and services nationwide. Under the current CDC award, IDT is providing COVID-19 oligonucleotides. IDT has previously supported pandemic response efforts through federal contracts and serves other government customers including the National Institutes of Health, Department of Defense, and Department of Commerce.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $115.3k | 5/5/20 |